Search results
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 1 day ago(Photo Illustration by Jakub Porzycki/NurPhoto/Getty Images) Since last week, hundreds of social...
‘Inhumane’: Utah mom slaps drug company with lawsuit after suffering COVID vaccine trial injuries
Fox News via Yahoo News· 3 hours agoBrianne Dressen shared with Fox News Digital why she decided to file a lawsuit against AstraZeneca...
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity,...
Benzinga via Yahoo Finance· 24 hours agoThursday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the SUPERNOVA Phase 3...
AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
Clinical Trials Arena via Yahoo Finance· 8 hours agoAstraZeneca has announced that the Phase III SUPERNOVA clinical trial of its sipavibart (formerly...
AstraZeneca's COVID prevention drug cuts risk of disease in vulnerable patients
Reuters via AOL· 1 day agoThe long-acting antibody therapy called sipavibart showed a "statistically significant reduction" in...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 1 day agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
New virus variants threaten a summer Covid-19 wave, but experts say the risk remains uncertain
CNN.com· 5 hours agoCovid-19 levels are about the lowest they’ve ever been in the United States, but another new crop of...
AstraZeneca selects new heart failure target with BenevolentAI
Pharmaceutical Technology via Yahoo Finance· 1 day agoAstraZeneca has incorporated a new target for heart failure treatment into its discovery portfolio...
AstraZeneca's COVID prevention drug meets primary goals in late-stage study
Reuters· 1 day agoAstraZeneca's investigational COVID-19 prevention therapy met its primary goals in a late-stage...
Equities Analysts Offer Predictions for AstraZeneca PLC’s Q2 2024 Earnings (NASDAQ:AZN)
ETF DAILY NEWS· 1 day agoAstraZeneca PLC (NASDAQ:AZN – Free Report) – Research analysts at Zacks Research reduced their Q2 2024 earnings per share estimates for AstraZeneca in a ...